
WXIBF
Healthcare · Biotechnology · $25.32B market cap
$6.15-0.06 (-1.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 19, 2025 | After the close | — | 0.55 | — |
| Jun 19, 2025 | Before the open | — | 0.44 | — |
| Jun 30, 2021 | Time not confirmed | 0.00 | 0.03 | — |
| Mar 23, 2021 | Before the open | 0.00 | 0.03 | — |
| Dec 31, 2020 | Time not confirmed | 0.00 | 0.02 | — |
| Aug 17, 2020 | Before the open | 0.00 | 0.02 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | 0.01 | — |
| Mar 4, 2020 | Before the open | 0.00 | 0.01 | — |
| Dec 31, 2019 | Time not confirmed | 0.00 | 0.01 | — |
| Aug 19, 2019 | Before the open | 0.00 | 0.01 | — |
| Jun 30, 2019 | Time not confirmed | 0.00 | 0.01 | — |
| Mar 18, 2019 | Before the open | 0.00 | 0.01 | — |
| Dec 31, 2018 | Time not confirmed | 0.00 | 0.01 | — |
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from…
| Before the open |
| 0.00 |
| 0.01 |
| — |
| Jun 30, 2018 | Time not confirmed | 0.00 | 0.00 | — |
| Mar 19, 2018 | Time not confirmed | 0.00 | 0.01 | — |